Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay

Heart Rhythm

Volumn 4, Issue 4, 2007, Pages 461-468

  Baker, William L ^a,b,c   White, C Michael ^a,c,d   Kluger, Jeffrey ^b,c   Denowitz, Aaron ^a   Konecny, Christopher P ^a   Coleman, Craig I ^a,c,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b School of Medicine Farmington   (United States)

^c Section of Cardiology   (United States)

^d HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; INSULIN; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG MEGADOSE; DRUG USE; EMBASE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART INFARCTION; HEART VALVE SURGERY; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFORMATION RETRIEVAL; LENGTH OF STAY; LOW DRUG DOSE; MEDIASTINITIS; MEDLINE; META ANALYSIS; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STERNOTOMY; SURGICAL RISK; SYSTEMATIC REVIEW; THORAX SURGERY; URINARY TRACT INFECTION;

ADRENAL CORTEX HORMONES; AGED; ANTI-INFLAMMATORY AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 34247213346     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.11.026     Document Type: Article

References (40)

1. Mathew J.P., Fontes M.L., Tudor I.C., Ramsay J., Duke P., Mazer C.D., Barash P.G., Hsu P.H., and Mangano D.T. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291 (2004) 1720-1729
2. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.-Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.-J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., and Zamorano J.L. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 48 (2006) e149-e246
3. Hogue C.W., Creswell L.L., Gutterman D.D., and Fleisher L.A. Epidemiology, mechanisms, and risks. American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. CHEST 128 (2005) 9S-16S
4. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002) 232-244
5. Chaney M.A. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. CHEST 121 (2002) 921-931
6. Bruins P., te Velthuis H., Yazdanbakhsh A.P., Jansen P.G.M., van Hardevelt F.W.J., de Beaumont E.M.F.H., Wildevuur C.R.H., Eijsman L., Trouwborst L., and Hack C.E. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
7. Gaudino M., Andreotti F., Zamparelli R., Di Castelnuovo A., Nasso G., Burzotta F., Iacoviello L., Donati M.B., Schiavello R., Maseri A., and Possati G. The 174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 (2003) 195-199
8. Hall R.I., Smith M.S., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacologic considerations. Anesth Analg 85 (1997) 766-782
9. Jadad A.R., Moore A., Carroll D., Jenkinson C., Reynolds D.J.M., Gavaghan D.J., and McQuay H.J. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 17 (1996) 1-12
10. Chaney M.A., Nikolov M.P., Blakeman B., Bakhos M., and Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 87 (1998) 24-33
11. Yared J.P., Starr N.J., Torres F.K., Bashour C.A., Bourdakos G., Piedmonte M., Michener J.A., Davis J.A., and Rosenberger T.E. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 69 (2000) 1420-1424
12. Chaney M.A., Durazo-Arvizu R., Nikolov M.P., Blakeman B.P., and Bakhos M. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation. J Thorac Cardiovasc Surg 121 (2001) 561-569
13. Halvorsen P., Raeder J., White P.F., Almdahl S.M., Nordstrand K., Saatvedt K., and Veel T. The effect of dexamethasone on side effects after coronary revascularization procedures. Anesth Analg 96 (2003) 1578-1583
14. Celik J.B., Gormus N., Okesli S., Gormus Z.I., and Solak H. Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-α, IL-6, IL-8, IL-10. Perfusion 19 (2004) 185-191
15. Rubens F.D., Nathan H., Labow R., Williams K.S., Wozny D., Karsh J., Ruel M., and Mesana T. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 79 (2005) 655-665
16. Bingol H., Cingoz F., Balkan A., Kilic S., Bolcal C., Demirkilic U., and Tatar H. The effect of oral prednisolone with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery. J Cardiac Surg 20 (2005) 252-256
17. Prasongsukarn K., Abel J.G., Jamieson W.R.E., Cheung A., Russell J.A., Walley K.R., and Lichtenstein S.V. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 130 (2005) 93-98
18. Whitlock R.P., Young E., Noora J., Farrokhyar F., Blackall M., and Teoh K.H. Pulse low dose steroids attenuate post-cardiopulmonary bypass SIRS; SIRS I. J Surg Res 132 (2006) 188-194
19. Asimakopoulos G., and Gourlay T. A review of anti-inflammatory strategies in cardiac surgery. Perfusion 18 (2003) 7-12
20. Boyle E.M., Pohlman T.H., Johnson M.C., and Verrier E.D. The systemic inflammatory response. Ann Thorac Surg 64 (1997) S31-S37
21. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., Tracy R.P., Van Wagoner D.R., Psaty B.M., Lauer M.S., and Chung M.K. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
22. Psychari S.N., Apostolou T.S., Sinos L., Hamodraka E., Liakos G., and Kremastinos D.T. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95 (2005) 764-767
23. Ishii Y., Schuessler R.B., Gaynor S.L., Yamada K., Fu A.S., Boineau J.P., and Damiano R.J. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 111 (2005) 2881-2888
24. Cesari M., Penninx B.W.J.H., Newman C.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., Rubin S.M., Ding J., Simonsick E.M., Harris T.B., and Pahor M. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108 (2003) 2317-2322
25. Engelmann M.D.M., and Svendsen J.H. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26 (2005) 2083-2092
26. Schimmer B.P., and Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's the pharmacologic basis of therapeutics. 10th ed. (2001), McGraw-Hil, New York 1649-1678
27. Brotman D.J., Girod J.P., Garcia M.J., Patel J.V., Gupta M., Posch A., Saunders S., Lip G.Y.H., Worley S., and Reddy S. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 90 (2005) 3202-3208
28. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
29. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., Hart J.C., Herrmann H.C., Hillis L.D., Hutter Jr. A.M., Lytle B.W., Marlow R.A., Nugent W.C., and Orszulak T.A. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) (2006). http://www.acc.org/clinical/guidelines/cabg/cabg/pdf Available at http://www.acc.org/clinical/guidelines/cabg/cabg/pdf. Accessed on August 28, 2006.
30. Ravelli F., and Allessie M. Effects of atrial dilation on refractory period and vulnerability to atrial fibrillation in the isolated Langerdorff-perfused rabbit heart. Circulation 96 (1997) 1686-1695
31. Kalus J.S., Caron M.F., White C.M., Mather J.F., Gallagher R., Boden W.E., and Kluger J. Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol 94 (2004) 1423-1425
32. Czock D., Keller F., Rasche F.M., and Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44 (2005) 61-98
33. Patel A.A., White C.M., Gillespie E.L., Kluger J., and Coleman C.I. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health-Syst Pharm 63 (2006) 829-837
34. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., Crowe T., Howard G., Cooper C.J., Brodie B., Grines C.L., and DeMaria A.N. Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis. JAMA 291 (2004) 1071-1080
35. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
36. Patti G., Chello M., Candura D., Vincenzo P., D'Ambrosio A., Covino E., and Di Sciascio G. A randomized trial of atorvastatin for reduction of post-operative atrial fibrillation in patients undergoing cardiac surgery. Results from the ARMYDA-D (Atorvastatin for Reduction of Myocardial Dysrhythmias After Cardiac Surgery) study. Circulation 114 (2006) 1455-1461
37. Marin F., Pascual D.A., Roldan V., Arribas J.M., Ahumada M., Tornel P.L., Oliver C., Gomez-Plana J., Lip G.Y.H., and Valdes M. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97 (2006) 55-60
38. Amar D., Zhang H., Heerdt P.M., Park B., Fleisher M., and Thaler H.T. Statin use in associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. CHEST 128 (2005) 3421-3427
39. Cheruku K.K., Ghani A., Ahmad F., Pappas P., Silverman P.R., Zelinger A., and Silver M.A. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 7 (2004) 13-18
40. Nussmeier N.A., Whelton A.A., Brown M.T., Langford R.M., Hoeft A., Parlow J.L., Boyce S.W., and Verburg K.M. Complications of COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352 (2005) 1081-1091